Capricor Therapeutics (CAPR) Prepaid Assets (2010 - 2026)
Capricor Therapeutics' (CAPR) quarterly Prepaid Assets came in at $4.5 million in Q1 2026, up 216.81% year-on-year from $1.4 million in Q1 2025, and down 5.74% quarter-over-quarter from $4.8 million in Q4 2025.
Capricor Therapeutics (CAPR) Prepaid Assets (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $4.5 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 216.81% year-over-year to $4.5 million in Q1 2026; TTM through Mar 2026 was $4.5 million, a 216.81% increase from a year earlier, with the FY2025 full-year figure at $4.8 million, up 216.59% from the prior year.
- Prepaid Assets slipped to $4.5 million in Q1 2026 per CAPR's latest filing, from $4.8 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $4.8 million in Q4 2025 and bottomed at $343684.0 in Q3 2022.
- The 5-year median for Prepaid Assets is $943246.0 (2022), against an average of $1.4 million.
- Across the five-year window, Prepaid Assets fell 20.69% in 2022 and jumped 504.19% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $919892.0 in 2022, then grew by 8.25% to $995776.0 in 2023, then jumped by 50.73% to $1.5 million in 2024, then surged by 216.59% to $4.8 million in 2025, then slipped by 5.74% to $4.5 million in 2026.
- Per Business Quant, the three latest CAPR Prepaid Assets figures stand at $4.5 million (Q1 2026), $4.8 million (Q4 2025), and $2.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Capricor Therapeutics | 457.86 Mn | 457.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.48 Mn |
| Dec 31, 2025 | 4.75 Mn |
| Sep 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 385,065.00 |
| Jun 30, 2024 | 837,218.00 |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 995,776.00 |
| Sep 30, 2023 | 458,417.00 |
| Jun 30, 2023 | 583,835.00 |
| Mar 31, 2023 | 875,092.00 |
| Dec 31, 2022 | 919,892.00 |
| Sep 30, 2022 | 343,684.00 |
| Jun 30, 2022 | 659,269.00 |
| Mar 31, 2022 | 943,246.00 |
| Dec 31, 2021 | 1.16 Mn |
| Sep 30, 2021 | 278,909.00 |
| Jun 30, 2021 | 653,336.00 |